Gordon Stephen has filed 56 insider transactions across 1 company since January 2023.
Most recent transaction: a option exercise of 2060 shares of TransMedics Group, Inc. ($TMDX) on June 03, 2024.
Activity breakdown: 0 open-market purchases and 15 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 2060 | $38.46 | 23,359.0000 | 32,517,372 | 9.67% | 0.01% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 2060 | $135.93 | 21,299.0000 | 32,517,372 | 8.82% | 0.01% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 2060 | $0.00 | 15,417.0000 | 32,517,372 | 11.79% | 0.01% |
| May 29, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 2000 | $141.27 | 21,299.0000 | 32,517,372 | 8.58% | 0.01% |
| May 29, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 2000 | $16.14 | 23,299.0000 | 32,517,372 | 9.39% | 0.01% |
| May 29, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 5000 | $38.46 | 28,299.0000 | 32,517,372 | 21.46% | 0.02% |
| May 29, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 5000 | $13.28 | 33,299.0000 | 32,517,372 | 17.67% | 0.02% |
| May 29, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 1000 | $83.14 | 34,299.0000 | 32,517,372 | 3.00% | 0.00% |
| May 29, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 5000 | $66.10 | 39,299.0000 | 32,517,372 | 14.58% | 0.02% |
| May 29, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 9345 | $141.06 | 29,954.0000 | 32,517,372 | 23.78% | 0.03% |
| May 29, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 8655 | $141.80 | 21,299.0000 | 32,517,372 | 28.89% | 0.03% |
| May 29, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 2000 | $0.00 | 84.0000 | 32,517,372 | 95.97% | 0.01% |
| May 29, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 17,477.0000 | 32,517,372 | 22.24% | 0.02% |
| May 29, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 23,167.0000 | 32,517,372 | 17.75% | 0.02% |
| May 29, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 1000 | $0.00 | 17,690.0000 | 32,517,372 | 5.35% | 0.00% |
| May 29, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 15,022.0000 | 32,517,372 | 24.97% | 0.02% |
| May 6, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 15000 | $38.46 | 38,299.0000 | 32,517,372 | 64.38% | 0.05% |
| May 6, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 15000 | $128.00 | 23,299.0000 | 32,517,372 | 39.17% | 0.05% |
| May 6, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 15000 | $0.00 | 22,477.0000 | 32,517,372 | 40.02% | 0.05% |
| April 1, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 15000 | $38.46 | 38,299.0000 | 32,517,372 | 64.38% | 0.05% |
| April 1, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 15000 | $74.01 | 23,299.0000 | 32,517,372 | 39.17% | 0.05% |
| April 1, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 15000 | $0.00 | 37,477.0000 | 32,517,372 | 28.58% | 0.05% |
| March 8, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 1903 | $87.63 | 23,299.0000 | 32,517,372 | 7.55% | 0.01% |
| March 4, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 15000 | $38.46 | 40,202.0000 | 32,517,372 | 59.52% | 0.05% |
| March 4, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 15000 | $82.80 | 25,202.0000 | 32,517,372 | 37.31% | 0.05% |
| March 4, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 15000 | $0.00 | 52,477.0000 | 32,517,372 | 22.23% | 0.05% |
| Feb. 23, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | A | Common Stock | 12127 | $0.00 | 25,202.0000 | 32,517,372 | 92.75% | 0.04% |
| Feb. 23, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | A | Stock Option (Right to Buy) | 18690 | $0.00 | 18,690.0000 | 32,517,372 | 9999.99% | 0.06% |
| Feb. 1, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 8833 | $13.28 | 21,908.0000 | 32,517,372 | 67.56% | 0.03% |
| Feb. 1, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 3644 | $16.14 | 25,552.0000 | 32,517,372 | 16.63% | 0.01% |
| Feb. 1, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 2523 | $38.46 | 28,075.0000 | 32,517,372 | 9.87% | 0.01% |
| Feb. 1, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 15000 | $85.45 | 13,075.0000 | 32,517,372 | 53.43% | 0.05% |
| Feb. 1, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 8833 | $0.00 | 28,167.0000 | 32,517,372 | 23.87% | 0.03% |
| Feb. 1, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 3644 | $0.00 | 2,084.0000 | 32,517,372 | 63.62% | 0.01% |
| Feb. 1, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 2523 | $0.00 | 67,477.0000 | 32,517,372 | 3.60% | 0.01% |
| Jan. 2, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 15000 | $13.28 | 28,075.0000 | 32,517,372 | 114.72% | 0.05% |
| Jan. 2, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 15000 | $77.07 | 13,075.0000 | 32,517,372 | 53.43% | 0.05% |
| Jan. 2, 2024 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 15000 | $0.00 | 37,000.0000 | 32,517,372 | 28.85% | 0.05% |
| Nov. 17, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | G | Common Stock | 5714 | $0.00 | 13,075.0000 | 29,556,633 | 30.41% | 0.02% |
| Oct. 2, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 5000 | $16.14 | 23,789.0000 | 29,556,633 | 26.61% | 0.02% |
| Oct. 2, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 5000 | $54.22 | 18,789.0000 | 29,556,633 | 21.02% | 0.02% |
| Oct. 2, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 5,728.0000 | 29,556,633 | 46.61% | 0.02% |
| May 1, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 5000 | $16.14 | 23,789.0000 | 29,556,633 | 26.61% | 0.02% |
| May 1, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 5000 | $79.05 | 18,789.0000 | 29,556,633 | 21.02% | 0.02% |
| May 1, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 10,728.0000 | 29,556,633 | 31.79% | 0.02% |
| March 1, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 5000 | $16.14 | 23,789.0000 | 29,556,633 | 26.61% | 0.02% |
| March 1, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 5000 | $79.51 | 18,789.0000 | 29,556,633 | 21.02% | 0.02% |
| March 1, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 15,728.0000 | 29,556,633 | 24.12% | 0.02% |
| Feb. 20, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | A | Common Stock | 13075 | $0.00 | 18,789.0000 | 29,556,633 | 228.82% | 0.04% |
| Feb. 20, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | A | Stock Option (Right to Buy) | 20022 | $0.00 | 20,022.0000 | 29,556,633 | 9999.99% | 0.07% |
| Feb. 1, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 5000 | $16.14 | 10,714.0000 | 29,556,633 | 87.50% | 0.02% |
| Feb. 1, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 5000 | $62.64 | 5,714.0000 | 29,556,633 | 46.67% | 0.02% |
| Feb. 1, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 20,728.0000 | 29,556,633 | 19.43% | 0.02% |
| Jan. 17, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Common Stock | 5000 | $16.14 | 10,714.0000 | 29,556,633 | 87.50% | 0.02% |
| Jan. 17, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | S | Common Stock | 5000 | $60.12 | 5,714.0000 | 29,556,633 | 46.67% | 0.02% |
| Jan. 17, 2023 | TransMedics Group, Inc. | $TMDX | Gordon Stephen | Chief Financial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 25,728.0000 | 29,556,633 | 16.27% | 0.02% |